Full-Time

Vice President/Senior Vice President

Finance

Posted on 1/18/2025

Mammoth Biosciences

Mammoth Biosciences

51-200 employees

Develops CRISPR-based diagnostic tests

Biotechnology
Healthcare

Compensation Overview

$345k - $360kAnnually

Expert

San Bruno, CA, USA

Position is onsite in Mammoth Brisbane, CA.

Category
Corporate Finance
Financial Planning and Analysis (FP&A)
Risk Management
Finance & Banking
Required Skills
NetSuite
Financial analysis
Requirements
  • 15+ years of financial leadership experience in the biotech industry
  • Bachelors Degree in Finance, Accounting or Business
  • Experience with ERP systems, such as NetSuite
  • Experience with pre-revenue and commercial stage companies
  • Experience taking companies public and raising capital privately and publicly
Responsibilities
  • Provide senior leadership in all areas of finance, general management, reporting, financial planning and analysis, budgeting, controls, financial systems, accounting, capital markets and treasury
  • Provide strategic suggestions/inputs and help lead the development of processes and procedures to operate efficiently and support the Company’s evolution and growth
  • Support the CEO, COO/CFO and senior leadership in financing activities and investor management
  • Prepare materials for senior leadership, Board of Directors; participate in Board or committee meetings
  • Understand key business drivers, business trends and competitive analysis
  • Provide hands-on leadership and oversee the development of annual budgets, long-range plans, scenario planning, financial and valuation analyses to guide resource and capital allocation decisions, interfacing across G&A and R&D teams
  • Develop metrics and analyses to measure financial performance, including budget vs. actuals and latest estimates
  • Assess financial needs as well as strategically plan for current and future growth of the company
  • Support business and corporate development planning and activities as needed
  • Build, coach and lead a high-performing finance team that provides quality partnership throughout the organization
  • Responsible for the development and implementation of reliable and scalable operating and control processes with IPO readiness in mind
  • Ensure regulatory and corporate compliance regarding all financial functions
  • Oversee all banking operations and maintain appropriate corporate insurance program
Desired Qualifications
  • MBA and/or CPA license
  • Ability to apply sound, creative problem-solving techniques
  • Excellent oral, written and interpersonal communication skills
  • Ability to work well under pressure in a high-growth environment; willingness to roll up sleeves and pitch in wherever needed
  • Ability to build strong trusting relationships with the leadership team, the board, our investors, and the broader organization as a whole
  • Ability to manage dialogue and relationships with key external constituencies, including investment banks, audit firms, investors, etc.
  • Excellent business judgment, problem-solving and critical thinking skills to help address important business decisions
  • Wall Street experience and operational finance experience
  • Business development experience a plus

Mammoth Biosciences focuses on molecular diagnostics using CRISPR technology to develop rapid diagnostic tests that can identify ailments, including infectious diseases like COVID-19, at the point of care. This allows for immediate results, reducing the wait time associated with traditional lab tests. The company differentiates itself with its versatile CRISPR-based detection platform, which offers a wide range of testing applications. Mammoth's goal is to improve the accessibility and efficiency of diagnostic testing to enhance health outcomes.

Company Stage

Late Stage VC

Total Funding

$353.3M

Headquarters

Brisbane, California

Founded

2017

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

-4%
Simplify Jobs

Simplify's Take

What believers are saying

  • Collaboration with Regeneron enhances CRISPR-based gene-editing capabilities.
  • $95 million investment from Regeneron boosts financial resources for CRISPR advancements.
  • Presentation at ASGCT highlights progress in ultracompact CRISPR systems for genetic diseases.

What critics are saying

  • Emerging competition from companies like VedaBio challenges market position.
  • Recent layoffs may indicate internal challenges or strategic shifts.
  • Regulatory hurdles could delay market entry for gene-editing therapies.

What makes Mammoth Biosciences unique

  • Mammoth Biosciences leverages novel CRISPR systems like Cas12, Cas13, and Cas14.
  • Co-founded by CRISPR pioneer Jennifer Doudna, enhancing credibility and innovation.
  • Focuses on democratizing disease detection with affordable, real-time point-of-care tests.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Medical, dental, & vision

401(k)

Unlimited vacation

Transportation subsidy

Onsite amenities

Happy hours

INACTIVE